BEAM:NASDAQ
Beam Therapeutics Inc
$24.60
arrow_downward
-0.69%(-0.17) 1D
$24.36
arrow_downward
-0.98% (-0.24)bedtimeAfter hours
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
$24.26
High
$24.69
Low
$23.91
Mkt. cap
2.54B
Avg. vol.
1.88M
Volume
2.43M
52-wk high
$38.26
52-wk low
$20.23
EPS
-$0.81
Beta
2.20
Shares outstanding
103.29M
No. of employees
540
Open
$24.26
High
$24.69
Low
$23.91
Mkt. cap
2.54B
Avg. vol.
1.88M
Volume
2.43M
52-wk high
$38.26
52-wk low
$20.23
EPS
-$0.81
Beta
2.20
Shares outstanding
103.29M
No. of employees
540
News stories
From web sources and news partners
Simply Wall Street
·
4 hours ago
Does Trade Secret Lawsuit Change The Bull Case For Beam Therapeutics Stock?
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc